Starling Oncology, Inc. Proceeds from Stock Options Exercised
Starling Oncology, Inc. (DFPH) reported Proceeds from Stock Options Exercised of $111.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-06
- Starling Oncology, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $90.00K, a 95.91% decline year-over-year.
- Starling Oncology, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $21.00K, a 84.67% decline year-over-year.
- Starling Oncology, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $72.00K.
- Starling Oncology, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $355.00K.
- Starling Oncology, Inc. proceeds from stock options exercised for fiscal 2025 was $2.77M, a 3589.33% increase from fiscal 2024.
- Starling Oncology, Inc. proceeds from stock options exercised for fiscal 2024 was $75.00K, a 40.48% decline from fiscal 2023.
- Starling Oncology, Inc. proceeds from stock options exercised for fiscal 2023 was $126.00K, a 85.31% decline from fiscal 2022.
- Starling Oncology, Inc. proceeds from stock options exercised for fiscal 2022 was $858.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $111.00K 10-Q · filed 2026-08-06 | $183.00K derived: sum of 3 quarters · filed 2026-08-06 | $538.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $21.00K 10-Q · filed 2026-05-07 | $93.00K derived: sum of 2 quarters · filed 2026-05-07 | $448.00K derived: sum of 3 quarters · filed 2026-05-07 | $2.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $427.00K derived: sum of 2 quarters · filed 2026-03-12 | $2.63M derived: sum of 3 quarters · filed 2026-08-06 | $2.77M 10-K · filed 2026-03-12 |
| 2025-09-30 | $355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.56M derived: sum of 2 quarters · filed 2026-08-06 | $2.69M 10-Q · filed 2025-11-13 | $2.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.34M 10-Q · filed 2026-08-06 | $2.34M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-03-31 | $137.00K 10-Q · filed 2026-05-07 | $137.00K derived: sum of 2 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $75.00K 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $75.00K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $126.00K 10-K · filed 2024-03-28 | |||
| 2022-12-31 | $858.00K 10-K · filed 2024-03-28 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | |||
| 2020-12-31 | $50.00K 10-K · filed 2022-03-11 |